• Sirolimus Market Purview - Report Description, Executive Summary, and Coherent Opportunity
Map (COM)
• Sirolimus Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory
Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain
Analysis, Porter’s Analysis, and PEST Analysis
• Global Sirolimus Market, By Regions
• Sirolimus Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Sirolimus Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Sirolimus Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers
of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Sirolimus Market Forecast including Production, Consumption, Import and Export Forecast by
Type, Applications and Region.
• Research Findings and Conclusion
Moreover, rising incidence of Alagille syndrome, Cystinosis, Glomerulonephritis, Nephrotic
syndrome, thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS),
Interstitial nephritis, and others is expected to result in increasing demand for transplants.
Major market players are engaged in research and development activities and product launches
in order to introduce optimized dosage forms. For instance, in 2014, Rapamune, a formulation
developed by Pfizer, lost its exclusivity as an immunosuppressant for kidney transplant rejection
management in the U.S. However, in 2015, Rapamune became the first U.S. FDA approved
drug for treating Lymphangioleiomyomatosis (LAM) which is a rare progressive lung disease.
These factors are expected to support global sirolimus market growth over the forecast period.
Global Sirolimus Market Regional Insights
North America is expected to dominate the global sirolimus market due to an increasing
number of product approvals for preventing organ transplant rejection. For instance, one of the
major leading company Pfizer Inc. has carried out various clinical trial studies on sirolimus
1mg/2mg dose for different treatments such as graft rejection, kidney transplant, renal allograft